GTR Test Accession:
Help
GTR000607940.1
CAP
Registered in GTR:
2023-07-17
View version history
GTR000607940.1,
registered in GTR:
2023-07-17
Last annual review date for the lab: 2022-10-27
Past due
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Drug Response;
Monitoring; ...
Conditions (1):
Help
Acute myeloid leukemia
Genes (52):
Help
Methods (1):
Help
Molecular Genetics - Mutation scanning of select exons: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Acute myeloid leukemia, myeodysplastic syndromes, primary myelifibrosis
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
MMP
Specimen Source:
Help
- Bone marrow
- Buccal swab
- Cell culture
- Isolated DNA
- Peripheral (whole) blood
Who can order: Help
- Licensed Physician
Test Order Code:
Help
CPT codes:
Help
Lab contact:
Help
Farid Chehab, PhD, MB(ASCP), Lab Director
farid.chehab@ucsf.edu
415-476-0310
Erik Samayoa, CLS, Laboratory Supervisor
Erik.Samayoa@ucsf.edu
415-514-8488
farid.chehab@ucsf.edu
415-476-0310
Erik Samayoa, CLS, Laboratory Supervisor
Erik.Samayoa@ucsf.edu
415-514-8488
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test strategy,
Test development
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 52
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Mutation scanning of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Illumina MiSeq
Clinical Information
Test purpose:
Help
Diagnosis;
Drug Response;
Monitoring;
Prognostic;
Therapeutic management
Target population:
Help
Acute myeloid leukemia, myeodysplastic syndromes, primary myelifibrosis
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
Unlisted or low population frequency in GnomAD, and absent from clinical databases
Unlisted or low population frequency in GnomAD, and absent from clinical databases
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
No.
No.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Yes. The ordering physician will be contacted for issues on interpretation, ordering of follow-up tests or for patient clinical information.
Yes. The ordering physician will be contacted for issues on interpretation, ordering of follow-up tests or for patient clinical information.
Recommended fields not provided:
Clinical validity,
Clinical utility,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Analytical sensitivity 1% Variant Allele Frequency (VAF)
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Description of PT method: Help
Next Generation Sequencing
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Description of PT method: Help
Next Generation Sequencing
VUS:
Laboratory's policy on reporting novel variations
Help
Unlisted or low population frequency in GnomAD, and absent from clinical databases
Unlisted or low population frequency in GnomAD, and absent from clinical databases
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.